重型创伤性脑损伤的多基因易感性与颅内高压、血肿进展及预后
本探索性研究分析492例前瞻性入组的重型TBI患者,围绕SUR1-TRPM4通道构建调控网络并评估单核苷酸变异与颅内压、脑实质出血进展及GOS评分的关系。结果显示多基因风险评分与全部结局相关且效应较大,明显提升模型解释力与判别性能,提示遗传因素在继发性损伤中起重要作用。
要点
- 围绕SUR1-TRPM4的多基因变异与重型TBI后继发性损伤及预后相关
- 多基因风险评分与颅内压、血肿进展和GOS均相关,并提升模型性能
- 相关变异涉及钙转运、谷氨酸清除、神经炎症和细胞死亡等通路
核心结论
- 与SUR1-TRPM4相关的关键节点多基因变异与重型TBI机制相关的继发性损伤及预后相关,提示遗传度起重要作用。
- 研究结果提示生物学合理性并识别新靶点,但数据仍需验证。
- 作者支持将生物学相关遗传信息纳入精准医学的推进方向。
研究设计与样本
- 探索性研究,分析492例前瞻性入组的重型TBI患者。
- 生物信息学构建SUR1-TRPM4上游/下游调控因子、介质与效应器网络。
- 评估单核苷酸变异与颅内压、脑实质出血进展及GOS评分的多变量模型关联,并构建加权/非加权多基因风险评分。
- 采用空间建模与功能预测,并在平行小鼠TBI模型中评估单细胞皮层转录组差异。
主要发现
- 相关功能包括Ca2+转运/信号、谷氨酸清除、神经炎症和细胞死亡。
- 单细胞分析显示细胞特异性基因表达差异;SNV为脑特异性cis-eQTL/错义/移码突变,提示高生物学影响可能。
关键数值与推荐
- 多基因风险评分与全部结局相关并改善R2与ROC。
临床怎么用
- 对重型TBI患者,可关注与SUR1-TRPM4网络相关的遗传变异以评估继发性损伤与预后风险。
- 多基因风险评分有助提升风险分层模型的解释力与判别性能,但需外部验证后用于临床。
- 遗传信息提示的钙转运、谷氨酸清除、神经炎症等通路可作为潜在干预靶点研究方向。
局限性
- 为探索性研究,作者指出数据仍需验证。
- 遗传关联基于候选网络分析,因果推断受限。
- 单细胞转录组差异来自平行小鼠TBI模型,向人转化需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Growing evidence underscores the importance of host-response/secondary-injury-likely influenced by genetics-in outcome variability post-traumatic brain injury (TBI). Intracranial hypertension and hemorrhage progression are critical secondary injuries in severe TBI; these are mediated by the SUR1-TRPM4 channel (a target in clinical trials). We aimed to deconstruct the complex network surrounding SUR1-TRPM4 and define the cumulative impact of key genetic variants on mechanistically connected secondary injuries/outcomes after severe TBI. METHODS: This exploratory study analyzed 492 prospectively enrolled patients with severe TBI. A network of regulators, mediators, and effectors upstream/downstream of SUR1-TRPM4 was bioinformatically constructed. Single nucleotide variants (SNVs) were evaluated for multivariable model association with intracranial pressure, intraparenchymal hemorrhage progression, and Glasgow Outcome Scale (GOS) score. Weighted/unweighted polygenic-risk scores (PRS) were constructed and interrogated. Spatial modeling and functional predictions were determined. Single-cell cortical transcriptomic differences were assessed in a parallel murine TBI model. RESULTS: Ninety-seven genes (625 SNVs) were analyzed. Nineteen genes contained variants associated with all outcomes (intracranial pressure, hemorrhage progression, and GOS score; p < 0.05). Twenty-two genes (42 SNVs) retained significance for ≥ 1 outcome, with overlap across outcomes. Functions included Ca2+-transport/signaling, glutamate-clearance, neuroinflammation, and cell death. Single-cell analyses revealed cell-specific gene-expression differences. SNVs were brain-specific cis-expression quantitative trait locus (eQTLs)/missense/frameshift mutations suggesting high likelihood of biological impact. PRSs were associated with all outcomes with large effects, and markedly improved model explanatory power/performance (R2, receiver operating characteristic [ROC]). INTERPRETATION: Polygenic variability in key nodes linked to SUR1-TRPM4 were associated with mechanistically related secondary injuries and outcome after severe TBI; findings suggest a major role of heritability. Functional implications indicate biological plausibility and identify novel targets. The data, whereas requiring validation, support a shift toward incorporating biologically relevant genetics in advancing precision medicine. ANN NEUROL 2026;99:459-477.
引用
- Miller ME, Zusman BE, Phuah CL, et al. Polygenic Vulnerability to Intracranial Hypertension, Hemorrhage Progression, and Outcome in Traumatic Brain Injury. Ann Neurol. 2025. PMID: 41235589. doi:10.1002/ana.78064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。